|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
1987-2-13
|
|
pubmed:abstractText |
I have found that antineoplastic drugs which are known to be inhibitors of mammalian DNA topoisomerases have pronounced and selective effects on simian virus 40 DNA replication. Ellipticine, 4'-(9-acridinylamino)methanesulfon-m-aniside, and Adriamycin blocked decatenation of newly replicated simian virus 40 daughter chromosomes in vivo. The arrested decatenation intermediates produced by these drugs contained single-strand DNA breaks. Ellipticine in particular produced these catenated dimers rapidly and efficiently. Removal of the drug resulted in rapid reversal of the block and completion of decatenation. The demonstration that these drugs interfere with decatenation suggests that they may exert their cytotoxic and antineoplastic effects by preventing the separation of newly replicated cellular chromosomes. Camptothecin rapidly breaks replication forks in growing Cairns structures. It is likely that the target of camptothecin is the "swivel" topoisomerase required for DNA replication and that it is located at or very near the replication fork in vivo. Evidence is presented that many of the broken Cairns structures are in fact half-completed sister chromatid exchanges. One pathway for the resolution of these structures is completion of the sister chromatid exchange to produce a circular head-to-tail dimer.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-1214832,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-15957215,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-206720,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-2985283,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-2985284,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-2988762,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-2996763,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-2997227,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-3000380,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-3000574,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-3004711,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-3004712,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-3004716,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-4291934,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-4342055,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-4891987,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-6086625,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-6090122,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-6093249,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-6250706,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-6264155,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-6269752,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-6297795,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-6300422,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-6323159,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-6324188,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-6326134,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-6448958,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-6788830,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-6895473,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3025645-7104026
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0270-7306
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4221-7
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:3025645-Amsacrine,
pubmed-meshheading:3025645-Animals,
pubmed-meshheading:3025645-Antineoplastic Agents,
pubmed-meshheading:3025645-Camptothecin,
pubmed-meshheading:3025645-Cell Line,
pubmed-meshheading:3025645-Cercopithecus aethiops,
pubmed-meshheading:3025645-DNA, Viral,
pubmed-meshheading:3025645-DNA Replication,
pubmed-meshheading:3025645-Doxorubicin,
pubmed-meshheading:3025645-Ellipticines,
pubmed-meshheading:3025645-Kidney,
pubmed-meshheading:3025645-Kinetics,
pubmed-meshheading:3025645-Nucleic Acid Conformation,
pubmed-meshheading:3025645-Simian virus 40,
pubmed-meshheading:3025645-Topoisomerase I Inhibitors
|
|
pubmed:year |
1986
|
|
pubmed:articleTitle |
Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
